Market Research Logo

United States Acinetobacter Infections Treatment Market Report 2018

United States Acinetobacter Infections Treatment Market Report 2018

In the last several years, global market of Acinetobacter Infections Treatment developed rapidly, with an average growth rate of 2.96%. In 2016, United States Market Size of Acinetobacter Infections Treatment is nearly 22 M USD. For developing product, there are 1 in Phase III, 1 in Phase ¢ò, 4 in Phase 1 and 8 in Preclinical. The total investment for Acinetobacter Infections Treatmen Drugs developing is around 90 M USD.

This report studies the Acinetobacter Infections Treatment development status and future trend in United States, focuses on top players in United States, also splits Acinetobacter Infections Treatment by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in United States market include
Entasis Therapeutics
Roche
Adenium Biotech
Vaxdyn
Hsiri Therapeutics
Aridis Pharmaceuticals
LegoChem Biosciences
Atterx Biotherapeutics
Achaogen
Peptilogics
Sealife PHARMA
Shionogi
Techulon
Tetraphase Pharmaceuticals

Geographically, this report splits the United States market into six regions,
Northeast
South Atlantic
West South Central
East North Central
Pacific
Other

On the basis of product, the Acinetobacter Infections Treatment market is primarily split into
Sulbactam
Carbapenems
Aminoglycosides
Polymyxins
Tetracyclines
Others

On the basis on the Pipeline this report covers
ETX2514
Nacubactam RG6080
Arenicin
VXD-001
Small molecule antibiotic
AR-401 mAB
LCB01-0371 (PO)
GN-4474
Antibacterial Antibody
eCAPs
SLP0904
S-649266 (cefiderocol)
Gram Negative (AcB)
TP-6076


1 Acinetobacter Infections Treatment Overview
1.1 Product Overview and Scope of Acinetobacter Infections Treatment
1.2 Classification of Acinetobacter Infections Treatment by Product Category
1.2.1 United States Acinetobacter Infections Treatment Revenue Comparison by Types (2012-2023)
1.2.2 United States Acinetobacter Infections Treatment Revenue Market Share by Types (Product Category) in 2016
1.2.3 Sulbactam
1.2.4 Carbapenems
1.2.5 Aminoglycosides
1.2.6 Polymyxins
1.2.7 Tetracyclines
1.3 United States Acinetobacter Infections Treatment Market by Pipeline
1.4 United States Acinetobacter Infections Treatment Market by Regions
1.4.1 United States Acinetobacter Infections Treatment Market Size (M USD) Comparison by Regions (2012-2023)
1.4.2 Northeast Acinetobacter Infections Treatment Status and Prospect (2012-2023)
1.4.3 South Atlantic Acinetobacter Infections Treatment Status and Prospect (2012-2023)
1.4.4 West South Central Acinetobacter Infections Treatment Status and Prospect (2012-2023)
1.4.5 East North Central Acinetobacter Infections Treatment Status and Prospect (2012-2023)
1.4.6 Pacific of US Acinetobacter Infections Treatment Status and Prospect (2012-2023)
1.5 United States Market Size (Sales and Revenue) of Acinetobacter Infections Treatment (2012-2023)
1.5.1 United States Acinetobacter Infections Case and Growth Rate (2012-2023)
1.5.2 United States Acinetobacter Infections Treatment Revenue and Growth Rate (2012-2023)
2 United States Acinetobacter Infections Treatment Market Competition by Players/Manufacturers
2.1 United States Acinetobacter Infections Treatment Pipeline of Key Players/Manufacturers in 2017
2.2 United States Acinetobacter Infections Treatment R&D Investment and Share by Players/Manufacturers (2016-2017)
2.3 United States Acinetobacter Infections Treatment R&D Investment Market Competitive Situation and Trends
2.3.1 United States Acinetobacter Infections Treatment Market Concentration Rate
2.3.2 United States Acinetobacter Infections Treatment Market Share of Top 3 and Top 5 Players/Manufacturers
2.4 United States Players/Manufacturers Acinetobacter Infections Treatment Headquarters, Established and Pipeline
3 United States Acinetobacter Infections Treatment Case and Revenue by Regions (2012-2017)
3.1 United States Acinetobacter Infections Case and Share by Regions (2012-2017)
3.2 United States Acinetobacter Infections Treatment Revenue and Market Share by Regions (2012-2017)
3.3 United States Acinetobacter Infections Treatment Cost by Regions (2012-2017)
4 United States Acinetobacter Infections Treatment Revenue by Type/ Product Category (2012-2017)
4.1 United States Acinetobacter Infections Treatment Revenue and Market Share by Type (2012-2017)
4.2 United States Acinetobacter Infections Treatment Sales Growth Rate (%) by Type (2012-2017)
5 United States Acinetobacter Infections Treatment Sales by Pipeline
5.1 United States Acinetobacter Infections Treatment Pipeline
5.2 United States Acinetobacter Infections Treatment Product Introduction
5.2.1 ETX2514 Introduction
5.2.2 Nacubactam RG6080 Introduction
5.2.3 Arenicin Introduction
5.2.4 VXD-001 Introduction
5.2.5 Small molecule antibiotic Introduction
5.2.6 AR-401 mAB Introduction
5.2.7 LCB01-0371 (PO) Introduction
5.2.8 GN-4474 Introduction
5.2.9 Antibacterial Antibody Introduction
5.2.10 eCAPs Introduction
5.2.11 SLP0904 Introduction
5.2.12 S-649266 (cefiderocol) Introduction
5.2.13 Gram Negative (AcB) Introduction
5.2.14 TP-6076
6 Analysis of Acinetobacter Infections Treatment Industry Key Manufacturers
6.1 Entasis Therapeutics
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Product, Stage and Investment
6.2 Roche
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Product, Stage and Investment
6.3 Adenium Biotech
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Product, Stage and Investment
6.4 Vaxdyn
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Product, Stage and Investment
6.5 Hsiri Therapeutics
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Product, Stage and Investment
6.6 Aridis Pharmaceuticals
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Product, Stage and Investment
6.7 LegoChem Biosciences
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Product, Stage and Investment
6.8 Atterx Biotherapeutics
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Product, Stage and Investment
6.9 Achaogen
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Product, Stage and Investment
6.10 Peptilogics
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Product, Stage and Investment
6.11 Sealife PHARMA
6.11.1 Company Profile
6.11.2 Product Information
6.11.3 Product, Stage and Investment
6.12 Shionogi
6.12.1 Company Profile
6.12.2 Product Information
6.12.3 Product, Stage and Investment
6.13 Techulon
6.13.1 Company Profile
6.13.2 Product Information
6.13.3 Product, Stage and Investment
6.14 Tetraphase Pharmaceuticals
6.14.1 Company Profile
6.14.2 Product Information
6.14.3 Product, Stage and Investment
7 Acinetobacter Infections Treatment Manufacturing Cost Analysis
7.1 Acinetobacter Infections Treatment R&D Cost Analysis
7.1.1 Clinical Phase Costs
7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.2.1 USA Labor Cost Analysis
7.2.2.2 Europe Labor Costs Analysis
7.2.2.3 Asia Labor Costs Analysis
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Acinetobacter Infections Treatment
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Acinetobacter Infections Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.2.1 Introducing pharmaceutical branding strategies
9.2.2.2 Building pharmaceutical brands
9.2.2.3 Communicating pharmaceutical brands
9.2.2.4 Alternative brand models
9.2.2.5 The future of pharmaceutical branding
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Acinetobacter Infections Treatment Market Size (Sales and Revenue) Forecast (2018-2023)
11.1 United States Acinetobacter Infections Treatment Sales Revenue Forecast (2018-2023)
11.2 United States Acinetobacter Infections Treatment Market Size Forecast by Type (2018-2023)
11.3 United States Acinetobacter Infections Treatment Market Size Forecast by Regions (2018-2023)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Acinetobacter Infections Treatment
Table United States Acinetobacter Infections Treatment Revenue (M USD) and Growth Rate Comparison by Types (Product Category) (2012-2023)
Figure United States Acinetobacter Infections Treatment Revenue Market Share by Types (Product Category) in 2016
Figure Sulbactam Product Picture
Figure Carbapenems Product Picture
Figure Aminoglycosides Product Picture
Figure Polymyxins Product Picture
Figure Tetracyclines Product Picture
Table United States Acinetobacter Infections Treatment Comparison by Pipeline in 2017
Figure United States Acinetobacter Infections Treatment Comparison by Pipeline in 2017
Figure United States Acinetobacter Infections Treatment Market Size (M USD) Comparison by Regions (2012-2023)
Figure Northeast Acinetobacter Infections Treatment Revenue (M USD) and Growth Rate (2012-2023)
Figure South Atlantic Acinetobacter Infections Treatment Revenue (M USD) and Growth Rate (2012-2023)
Figure West South Central Acinetobacter Infections Treatment Revenue (M USD) and Growth Rate (2012-2023)
Figure East North Central Acinetobacter Infections Treatment Revenue (M USD) and Growth Rate (2012-2023)
Figure Pacific of US Acinetobacter Infections Treatment Revenue (M USD) and Growth Rate (2012-2023)
Figure United States Acinetobacter Infections Case and Growth Rate (2012-2023)
Figure United States Acinetobacter Infections Treatment Revenue (M USD) and Growth Rate (2012-2023)
Table United States Acinetobacter Infections Treatment Pipeline of Key Players/Manufacturers 2017
Table United States Acinetobacter Infections Treatment R&D Investment (M USD) by Players/Manufacturers (2016-2017)
Table United States Acinetobacter Infections Treatment R&D Investment Market Share by Players/Manufacturers (2016-2017)
Figure 2016 United States Acinetobacter Infections Treatment R&D Investment Market Share by Players/Manufacturers
Figure 2017 United States Acinetobacter Infections Treatment R&D Investment Market Share by Players/Manufacturers
Figure 2017 United States Acinetobacter Infections Treatment R&D Investment Market Share by Players/Manufacturers
Figure United States Acinetobacter Infections Treatment R&D Investment Market Share of Top 3 Players/Manufacturers
Figure United States Acinetobacter Infections Treatment R&D Investment Market Share of Top 5 Players/Manufacturers
Table United States Players/Manufacturers Acinetobacter Infections Treatment Headquarters and Established
Table United States Players/Manufacturers Acinetobacter Infections Treatment Product Pipeline
Table United States Acinetobacter Infections Case by Regions (2012-2017)
Table United States Acinetobacter Infections Case Share by Regions (2012-2017)
Figure United States Acinetobacter Infections Treatment Sales Share by Regions (2012-2017)
Figure United States Acinetobacter Infections Treatment Sales Market Share by Regions in 2016
Table United States Acinetobacter Infections Treatment Revenue (M USD) and Market Share by Regions (2012-2017)
Table United States Acinetobacter Infections Treatment Revenue Market Share by Regions (2012-2017)
Figure United States Acinetobacter Infections Treatment Revenue Market Share by Regions (2012-2017)
Figure United States Acinetobacter Infections Treatment Revenue Market Share by Regions in 2016
Table United States Acinetobacter Infections Treatment Cost (USD/Case) by Regions (2012-2017)
Table Dosing information, Acquisition and Administration Costs
Table United States Acinetobacter Infections Treatment Revenue (M USD) and Market Share by Type (2012-2017)
Table United States Acinetobacter Infections Treatment Revenue Market Share by Type (2012-2017)
Figure Revenue Market Share of Acinetobacter Infections Treatment by Type (2012-2017)
Figure Revenue Market Share of Acinetobacter Infections Treatment by Type in 2016
Figure United States Acinetobacter Infections Treatment Sales Growth Rate (%) by Type (2012-2017)
Table United States Acinetobacter Infections Treatment Pipeline of Key Players/Manufacturers 2017
Table S-649266 (cefiderocol) Introduction
Table Entasis Therapeutics Company Profile
Table Acinetobacter Infections Treatment Product Introduction of Entasis Therapeutics
Table Product, Stage and Investment (M USD) of Entasis Therapeutics 2016-2016
Table Roche Company Profile
Table Acinetobacter Infections Treatment Product Introduction of Roche
Table Product, Stage and Investment (M USD) of Roche 2016-2016
Table Adenium Biotech Company Profile
Table Acinetobacter Infections Treatment Product Introduction of Adenium Biotech
Table Product, Stage and Investment (M USD) of Adenium Biotech 2016-2016
Table Vaxdyn Company Profile
Table Acinetobacter Infections Treatment Product Introduction of Vaxdyn
Table Product, Stage and Investment (M USD) of Vaxdyn 2016-2016
Table Hsiri Therapeutics Company Profile
Table Acinetobacter Infections Treatment Product Introduction of Hsiri Therapeutics
Table Product, Stage and Investment (M USD) of Hsiri Therapeutics 2016-2016
Table Aridis Pharmaceuticals Company Profile
Table Acinetobacter Infections Treatment Product Introduction of Aridis Pharmaceuticals
Table Product, Stage and Investment (M USD) of Aridis Pharmaceuticals 2016-2016
Table LegoChem Biosciences Company Profile
Table Acinetobacter Infections Treatment Product Introduction of LegoChem Biosciences
Table Product, Stage and Investment (M USD) of LegoChem Biosciences 2016-2016
Table Atterx Biotherapeutics Company Profile
Table Acinetobacter Infections Treatment Product Introduction of Atterx Biotherapeutics
Table Product, Stage and Investment (M USD) of Atterx Biotherapeutics 2016-2016
Table Achaogen Company Profile
Figure Acinetobacter Infections Treatment Product Introduction of Achaogen
Table Product, Stage and Investment (M USD) of Achaogen 2016-2016
Table Peptilogics Company Profile
Table Acinetobacter Infections Treatment Product Introduction of Peptilogics
Table Product, Stage and Investment (M USD) of Peptilogics 2016-2016
Table Sealife PHARMA Company Profile
Table Acinetobacter Infections Treatment Product Introduction of Sealife PHARMA
Table Product, Stage and Investment (M USD) of Sealife PHARMA 2016-2016
Table Shionogi Company Profile
Table Acinetobacter Infections Treatment Product Introduction of Shionogi
Table Product, Stage and Investment (M USD) of Shionogi 2016-2016
Table Techulon Company Profile
Figure Acinetobacter Infections Treatment Product Introduction of Techulon
Table Product, Stage and Investment (M USD) of Techulon 2016-2016
Table Tetraphase Pharmaceuticals Company Profile
Table Acinetobacter Infections Treatment Product Introduction of Tetraphase Pharmaceuticals
Table Product, Stage and Investment (M USD) of Tetraphase Pharmaceuticals 2016-2016
Figure typical phases from research to the market for a drug candidate
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
Figure Manufacturing Cost Structure of Acinetobacter Infections Treatment
Figure Assessment of API Manufacturing Cost By Region
Figure USA Overview of Average Hourly Wages 2015-2016 (USD/Hour)
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points)
Figure Cost of Employing a Factory Worker
Figure 2015 Estimated Labor Costs for the Whole Economy in Europe
Figure Monthly Minimum Wages in Asia 2016
Figure China Overview of Average Yearly Wages 2015-2016 (CNY/Year)
Figure Japan Overview of Average Monthly Wages 2015-2016(JPY Thousand/Month)
Table 2015 Global Electricity Price of Industry (USD/KWh) by Country
Figure Manufacturing Process Analysis of Acinetobacter Infections Treatment
Figure Acinetobacter Infections Treatment Industrial Chain Analysis
Table Major Buyers of Acinetobacter Infections Treatment
Figure Marketing Channel for Biopharmaceuticals
Table Some of Famous Hospital
Table Distributors/Traders List
Table Multidrug-resistant Acinetobacter in USA
Figure Multidrug-resistant Acinetobacter in USA
Figure Global GDP Growth Rate for 2016
Figure US GDP 2006-2016 (Billion USD)
Figure US CPI Change 2016-2017
Figure EU GDP 2006-2016 (Billion USD)
Figure EU CPI Change 2012-2016
Figure Germany GDP 2006-2016 (Billion USD)
Figure Germany CPI Change 2016-2017
Figure UK GDP 2006-2016 (Billion USD)
Figure UK CPI Change 2016-2017
Figure Italy GDP 2006-2016 (Billion USD)
Figure Italy CPI Change 2016-2017
Figure Japan GDP 2006-2016 (Billion USD)
Figure Japan CPI Change 2012-2016
Figure China GDP 2006-2016 (Billion USD)
Figure China CPI Change 2016-2017
Figure United States Acinetobacter Infections Case and Growth Rate Forecast (2018-2023)
Figure United States Acinetobacter Infections Treatment Revenue (M USD) and Growth Rate Forecast (2018-2023)
Table United States Acinetobacter Infections Treatment Market Size (M USD) Forecast by Type (2018-2023)
Figure United States Acinetobacter Infections Treatment Market Size Share Forecast by Type (2018-2023)
Figure United States Acinetobacter Infections Treatment Market Size Share Market Share Forecast by Type in 2023
Table United States Acinetobacter Infections Treatment Market Size (M USD) Forecast by Regions (2018-2023)
Table United States Acinetobacter Infections Treatment Market Size Share Forecast by Regions (2018-2023)
Figure United States Acinetobacter Infections Treatment Market Size Share Forecast by Regions (2018-2023)
Figure United States Acinetobacter Infections Treatment Market Size Share Forecast by Regions in 2023
Table Research Programs/Design for This Report

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report